Cargando…

Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer’s Disease

BACKGROUND: Effectiveness of Alzheimer’s disease (AD) treatments may depend critically on the timeliness of intervention. OBJECTIVE: To compare characteristics and outcomes of patients diagnosed with probable AD (prAD) based on time elapsed from first onset of cognitive decline. METHODS: Patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirson, Noam Y., Scott Andrews, J., Desai, Urvi, King, Sarah B., Schonfeld, Sophie, Birnbaum, Howard G., Ball, Daniel E., Kahle-Wrobleski, Kristin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734126/ https://www.ncbi.nlm.nih.gov/pubmed/29154268 http://dx.doi.org/10.3233/JAD-170078

Ejemplares similares

Assessing the economic burden of Alzheimer’s disease patients first diagnosed by specialists
por: Kirson, Noam Y., et al.
Publicado: (2016)

Functional limitations and health care resource utilization for individuals with cognitive impairment without dementia: Findings from a United States population-based survey
por: Andrews, J. Scott, et al.
Publicado: (2016)

Excess Costs Associated with Possible Misdiagnosis of Alzheimer’s Disease Among Patients with Vascular Dementia in a UK CPRD Population
por: Happich, Michael, et al.
Publicado: (2016)

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
por: Andrews, J. Scott, et al.
Publicado: (2019)

Trends in health service use and potentially avoidable hospitalizations before Alzheimer's disease diagnosis: A matched, retrospective study of US Medicare beneficiaries
por: Desai, Urvi, et al.
Publicado: (2019)

Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019)
por: Andrews, J. Scott, et al.
Publicado: (2023)

Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2014)

Disease severity at the time of initial cognitive assessment is related to prior health‐care resource use burden
por: Desai, Urvi, et al.
Publicado: (2020)

Modeling the course of Alzheimer's disease to improve clinical trials: symposium report
por: Spiegel, René, et al.
Publicado: (2013)

Using U.S. Medicare records to evaluate the indirect health effects on spouses: a case study in Alzheimer’s disease patients
por: Gilden, Daniel M, et al.
Publicado: (2014)

Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
por: Montgomery, William, et al.
Publicado: (2018)

Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan
por: Hadjiyianni, Irene, et al.
Publicado: (2016)

Alzheimer’s disease severity and its association with patient and caregiver quality of life in Japan: results of a community-based survey
por: Montgomery, William, et al.
Publicado: (2018)

Impact of caring for persons with Alzheimer’s disease or dementia on caregivers’ health outcomes: findings from a community based survey in Japan
por: Goren, Amir, et al.
Publicado: (2016)

Understanding the Complexities of Functional Ability in Alzheimer’s Disease: More Than Just Basic and Instrumental Factors
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2014)

The experience of a severe hypoglycaemic event from the perspective of people with diabetes and their caregivers: “What am I going to do?”
por: Stuckey, Heather L., et al.
Publicado: (2021)

Assessing quality of life in Alzheimer's disease: Implications for clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2016)

The influence of caregivers and behavioral and psychological symptoms on nursing home placement of persons with Alzheimer’s disease: A matched case–control study
por: Porter, Candace N, et al.
Publicado: (2016)

Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model
por: Furiak, Nicolas M, et al.
Publicado: (2010)

Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer’s disease diagnosis: a pilot study in England
por: Dell’Agnello, Grazia, et al.
Publicado: (2018)

Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database
por: Chandler, Julie, et al.
Publicado: (2022)

Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
por: Reed, Catherine, et al.
Publicado: (2018)

Biomarkers for Alzheimer's disease: Earlier, easier, and fairer
por: eBioMedicine
Publicado: (2022)

Estimating the health care burden of prescription opioid abuse in five European countries
por: Shei, Amie, et al.
Publicado: (2015)

Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer’s disease
por: Lebrec, Jeremie, et al.
Publicado: (2016)

Value of total cholesterol readings earlier versus later in life to predict cardiovascular risk
por: Leiherer, Andreas, et al.
Publicado: (2021)

The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes
por: Lachin, John M., et al.
Publicado: (2021)

How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study
por: Belger, Mark, et al.
Publicado: (2016)

Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer’s Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study
por: Nakanishi, Miharu, et al.
Publicado: (2020)

Estimating the Costs of Opioid Abuse and Dependence from an Employer Perspective: a Retrospective Analysis Using Administrative Claims Data
por: Rice, J. Bradford, et al.
Publicado: (2014)

Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes
por: Jones, Roy W., et al.
Publicado: (2017)

How to measure which sort of particles was emitted earlier and which later
por: Lednicky, R, et al.
Publicado: (1994)

Characteristics of High-Cost Patients Diagnosed with Opioid Abuse
por: Shei, Amie, et al.
Publicado: (2015)

2145. Economic Burden of Congenital Cytomegalovirus Infection in Commercially- and Medicaid-insured Patients in the United States
por: Diaz-Decaro, John D, et al.
Publicado: (2022)

Metformin: Expanding the Scope of Application—Starting Earlier than Yesterday, Canceling Later
por: Kononova, Yulia A., et al.
Publicado: (2022)

Decomposition of multivariate probabilities
por: Cuppens, Roger, et al.
Publicado: (1975)

Real analysis and probability
por: Ash, Robert B, et al.
Publicado: (1972)

The Earlier Years
Publicado: (2001)

CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression
por: Martinelli, Marcella, et al.
Publicado: (2016)

Earlier Age of Smoking Initiation May Not Predict Heavier Cigarette Consumption in Later Adolescence
por: Morrell, Holly E. R., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_uepqdod42cbiug7nd4j025df1m